Skip to main content
Top
Published in: AIDS and Behavior 5/2011

01-07-2011 | Original Paper

Group Motivational Interviewing to Promote Adherence to Antiretroviral Medications and Risk Reduction Behaviors in HIV Infected Women

Authors: Marcia McDonnell Holstad, Colleen DiIorio, Mary E. Kelley, Kenneth Resnicow, Sanjay Sharma

Published in: AIDS and Behavior | Issue 5/2011

Login to get access

Abstract

We present the results of a clinical trial that tested the efficacy of using motivational interviewing (MI) in a group format to promote adherence to antiretroviral medications and risk reduction behaviors (RRB) in 203 predominately African American HIV infected women. It was compared to a group health promotion program. Participants were followed for 9 months. Adherence was measured by MEMS®; and RRB by self-report. Controlling for recruitment site and years on ART, no significant group by time effects were observed. Attendance (≥7/8 sessions) modified the effects. Higher MI attendees had better adherence at all follow-ups, a borderline significant group by time effect (p = 0.1) for % Doses Taken on Schedule, a significantly larger proportion who reported abstinence at 2 weeks, 6, and 9 months, and always used protection during sex at 6 and 9 months. Though not conclusive, the findings offer some support for using MI in a group format to promote adherence and some risk reduction behaviors when adequate attendance is maintained.
Literature
1.
go back to reference CDC. Effect of antiretroviral therapy on risk of sexual transmission of HIV infection and superinfection: centers for disease control and prevention. 2009 September. CDC. Effect of antiretroviral therapy on risk of sexual transmission of HIV infection and superinfection: centers for disease control and prevention. 2009 September.
2.
go back to reference CDC. Recommendations for use of antiretroviral drugs in pregnant HIV-infected women for maternal health and interventions to reduce perinatal HIV transmission in the United States. 2009 [cited 2009 October 18]. CDC. Recommendations for use of antiretroviral drugs in pregnant HIV-infected women for maternal health and interventions to reduce perinatal HIV transmission in the United States. 2009 [cited 2009 October 18].
3.
go back to reference Remien RH, Exner T, Kertzner RM, Ehrhardt AA, Rotheram-Borus MJ, Johnson MO, et al. Depressive symptomatology among HIV-positive women in the era of HAART: a stress and coping model. Am J Community Psychol. 2006;38(3–4):275–85.PubMedCrossRef Remien RH, Exner T, Kertzner RM, Ehrhardt AA, Rotheram-Borus MJ, Johnson MO, et al. Depressive symptomatology among HIV-positive women in the era of HAART: a stress and coping model. Am J Community Psychol. 2006;38(3–4):275–85.PubMedCrossRef
4.
go back to reference Wilson TE, Barron Y, Cohen M, Richardson J, Greenblatt R, Sacks HS, et al. Adherence to antiretroviral therapy and its association with sexual behavior in a national sample of women with human immunodeficiency virus. Clin Infect Dis. 2002;34(4):529–34.PubMedCrossRef Wilson TE, Barron Y, Cohen M, Richardson J, Greenblatt R, Sacks HS, et al. Adherence to antiretroviral therapy and its association with sexual behavior in a national sample of women with human immunodeficiency virus. Clin Infect Dis. 2002;34(4):529–34.PubMedCrossRef
5.
go back to reference Kalichman S, Rompa D. HIV treatment adherence and unprotected sex practices in people receiving antiretroviral therapy. Sex Transm Infect. 2003;79:59–61.PubMedCrossRef Kalichman S, Rompa D. HIV treatment adherence and unprotected sex practices in people receiving antiretroviral therapy. Sex Transm Infect. 2003;79:59–61.PubMedCrossRef
6.
go back to reference Diamond C, Richardson JL, Milam J, Stoyanoff S, McCutchan JA, Kemper C, et al. Use of and adherence to antiretroviral therapy is associated with decreased sexual risk behavior in HIV clinic patients. J AIDS. 2005;39(2):211–8. Diamond C, Richardson JL, Milam J, Stoyanoff S, McCutchan JA, Kemper C, et al. Use of and adherence to antiretroviral therapy is associated with decreased sexual risk behavior in HIV clinic patients. J AIDS. 2005;39(2):211–8.
7.
go back to reference Remien RH, Exner TM, Morin SF, Ehrhardt AA, Johnson MO, Correale J, et al. Medication adherence and sexual risk behavior among HIV-infected adults: implications for transmission of resistant virus. AIDS Behav. 2007;11(5):663–75.PubMedCrossRef Remien RH, Exner TM, Morin SF, Ehrhardt AA, Johnson MO, Correale J, et al. Medication adherence and sexual risk behavior among HIV-infected adults: implications for transmission of resistant virus. AIDS Behav. 2007;11(5):663–75.PubMedCrossRef
8.
go back to reference Donnell D, Baeten jM, Kiarie j, Thomas KK, Stevens W, Cohen CR, McIntyre J, Lingappa JR, Celum C. Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis. Lancet. 2010;375:2092–8.PubMedCrossRef Donnell D, Baeten jM, Kiarie j, Thomas KK, Stevens W, Cohen CR, McIntyre J, Lingappa JR, Celum C. Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis. Lancet. 2010;375:2092–8.PubMedCrossRef
9.
go back to reference Bennett JA, Young HM, Nail LM, Winters-Stone K, Hanson G. A telephone-only motivational intervention to increase physical activity in rural adults: a randomized controlled trial. Nurs Res. 2008;57(1):24–32.PubMedCrossRef Bennett JA, Young HM, Nail LM, Winters-Stone K, Hanson G. A telephone-only motivational intervention to increase physical activity in rural adults: a randomized controlled trial. Nurs Res. 2008;57(1):24–32.PubMedCrossRef
10.
go back to reference Resnicow K, Wallace DC, Jackson A, Digirolamo A, Odom E, Wang T, et al. Dietary change through African American churches: baseline results and program description of the eat for life trial. J Cancer Educ. 2000;15(3):156–63. Resnicow K, Wallace DC, Jackson A, Digirolamo A, Odom E, Wang T, et al. Dietary change through African American churches: baseline results and program description of the eat for life trial. J Cancer Educ. 2000;15(3):156–63.
11.
go back to reference Smith DE, Heckemeyer CM, Kratt PP, Mason DA. Motivational interviewing to improve adherence to a behavioral weight-control program for older obese women with NIDDM. A pilot study. Diabetes Care. 1997;20(1):52–4.PubMedCrossRef Smith DE, Heckemeyer CM, Kratt PP, Mason DA. Motivational interviewing to improve adherence to a behavioral weight-control program for older obese women with NIDDM. A pilot study. Diabetes Care. 1997;20(1):52–4.PubMedCrossRef
12.
go back to reference Stein MD, Herman DS, Anderson BJ. A motivational intervention trial to reduce cocaine use. J Subst Abuse Treat. 2009;36(1):118–25.PubMedCrossRef Stein MD, Herman DS, Anderson BJ. A motivational intervention trial to reduce cocaine use. J Subst Abuse Treat. 2009;36(1):118–25.PubMedCrossRef
13.
go back to reference Parsons JT, Golub SA, Rosof E, Holder C. Motivational interviewing and cognitive-behavioral intervention to improve HIV medication adherence among hazardous drinkers: a randomized controlled trial. J AIDS. 2007;46(4):443–50. Parsons JT, Golub SA, Rosof E, Holder C. Motivational interviewing and cognitive-behavioral intervention to improve HIV medication adherence among hazardous drinkers: a randomized controlled trial. J AIDS. 2007;46(4):443–50.
14.
go back to reference Velasquez MM, von Sternberg K, Johnson DH, Green C, Carbonari JP, Parsons JT. Reducing sexual risk behaviors and alcohol use among HIV-positive men who have sex with men: a randomized clinical trial. J Consult Clin Psychol. 2009;77(4):657–67.PubMedCrossRef Velasquez MM, von Sternberg K, Johnson DH, Green C, Carbonari JP, Parsons JT. Reducing sexual risk behaviors and alcohol use among HIV-positive men who have sex with men: a randomized clinical trial. J Consult Clin Psychol. 2009;77(4):657–67.PubMedCrossRef
15.
go back to reference DiIorio C, McCarty F, Resnicow K, McDonnell Holstad M, Soet J, Yeager K, et al. Using motivational interviewing to promote adherence to antiretroviral medications: a randomized controlled study. AIDS Care. 2008;20(3):273–83.PubMedCrossRef DiIorio C, McCarty F, Resnicow K, McDonnell Holstad M, Soet J, Yeager K, et al. Using motivational interviewing to promote adherence to antiretroviral medications: a randomized controlled study. AIDS Care. 2008;20(3):273–83.PubMedCrossRef
16.
go back to reference Golin CE, Earp J, Tien HC, Stewart P, Porter C, Howie L. A 2-arm, randomized, controlled trial of a motivational interviewing-based intervention to improve adherence to antiretroviral therapy (ART) among patients failing or initiating ART. J AIDS. 2006;42(1):42–51. Golin CE, Earp J, Tien HC, Stewart P, Porter C, Howie L. A 2-arm, randomized, controlled trial of a motivational interviewing-based intervention to improve adherence to antiretroviral therapy (ART) among patients failing or initiating ART. J AIDS. 2006;42(1):42–51.
17.
go back to reference Fisher JD, Fisher WA, Cornman DH, Amico RK, Bryan A, Friedland GH. Clinician-delivered intervention during routine clinical care reduces unprotected sexual behavior among HIV-infected patients. J AIDS. 2006;41(1):44–52. Fisher JD, Fisher WA, Cornman DH, Amico RK, Bryan A, Friedland GH. Clinician-delivered intervention during routine clinical care reduces unprotected sexual behavior among HIV-infected patients. J AIDS. 2006;41(1):44–52.
18.
go back to reference Callahan EJ, Flynn NM, Kuenneth CA, Enders SR. Strategies to reduce HIV risk behavior in HIV primary care clinics: brief provider messages and specialist intervention. AIDS Behav. 2007;11(5 Suppl):S48–57.PubMedCrossRef Callahan EJ, Flynn NM, Kuenneth CA, Enders SR. Strategies to reduce HIV risk behavior in HIV primary care clinics: brief provider messages and specialist intervention. AIDS Behav. 2007;11(5 Suppl):S48–57.PubMedCrossRef
19.
go back to reference Golin CE, Patel S, Tiller K, Quinlivan EB, Grodensky CA, Boland M. Start talking about risks: development of a motivational interviewing-based safer sex program for people living with HIV. AIDS Behav. 2007;11(5 Suppl):S72–83.PubMedCrossRef Golin CE, Patel S, Tiller K, Quinlivan EB, Grodensky CA, Boland M. Start talking about risks: development of a motivational interviewing-based safer sex program for people living with HIV. AIDS Behav. 2007;11(5 Suppl):S72–83.PubMedCrossRef
20.
go back to reference Nollen C, Drainoni ML, Sharp V. Designing and delivering a prevention project within an HIV treatment setting: lessons learned from a specialist model. AIDS Behav. 2007;11(5 Suppl):S84–94.PubMedCrossRef Nollen C, Drainoni ML, Sharp V. Designing and delivering a prevention project within an HIV treatment setting: lessons learned from a specialist model. AIDS Behav. 2007;11(5 Suppl):S84–94.PubMedCrossRef
21.
go back to reference Rutledge SE. Single-session motivational enhancement counseling to support change toward reduction of HIV transmission by HIV positive persons. Arch Sex Behav. 2007;36(2):313–9.PubMedCrossRef Rutledge SE. Single-session motivational enhancement counseling to support change toward reduction of HIV transmission by HIV positive persons. Arch Sex Behav. 2007;36(2):313–9.PubMedCrossRef
22.
go back to reference Ingersoll K, Wagner C. Motivational enhancement groups for the Virginia substance abuse treatment outcome evaluation (SATOE) model: theoretical background and clinical guidelines. Richmond, VA: Virginia Addiction Technology Transfer Center Virginia Commonwealth University/Medical College of Virginia; 1998. Ingersoll K, Wagner C. Motivational enhancement groups for the Virginia substance abuse treatment outcome evaluation (SATOE) model: theoretical background and clinical guidelines. Richmond, VA: Virginia Addiction Technology Transfer Center Virginia Commonwealth University/Medical College of Virginia; 1998.
23.
go back to reference Morrison-Beedy D, Carey MP, Kowalski J, Tu X. Group-based HIV risk reduction intervention for adolescent girls: evidence of feasibility and efficacy. Res Nurs Health. 2005;28(1):3–15.PubMedCrossRef Morrison-Beedy D, Carey MP, Kowalski J, Tu X. Group-based HIV risk reduction intervention for adolescent girls: evidence of feasibility and efficacy. Res Nurs Health. 2005;28(1):3–15.PubMedCrossRef
24.
go back to reference Holstad MM, DiIorio C, Magowe MK. Motivating HIV positive women to adhere to antiretroviral therapy and risk reduction behavior: the KHARMA Project. Online J Issues Nurs. 2006;11(1):5.PubMed Holstad MM, DiIorio C, Magowe MK. Motivating HIV positive women to adhere to antiretroviral therapy and risk reduction behavior: the KHARMA Project. Online J Issues Nurs. 2006;11(1):5.PubMed
25.
go back to reference Ebbert DW, Connors H. Standardized patient experiences: evaluation of clinical performance and nurse practitioner student satisfaction. Nurs Educ Perspect. 2004;25(1):12–5.PubMed Ebbert DW, Connors H. Standardized patient experiences: evaluation of clinical performance and nurse practitioner student satisfaction. Nurs Educ Perspect. 2004;25(1):12–5.PubMed
26.
go back to reference CDC. Revision of the CDC surveillance case definition for acuired immunodeficiency syndrome. MMWR. 1987;36(1S):82–94. CDC. Revision of the CDC surveillance case definition for acuired immunodeficiency syndrome. MMWR. 1987;36(1S):82–94.
27.
go back to reference CDC. Core measures for HIV/STD risk behavior and prevention: Questionnaire-based measurement for surveys and other data systems. Sexual behavior questions version 5.00. 2001 [5/27/2003.]. CDC. Core measures for HIV/STD risk behavior and prevention: Questionnaire-based measurement for surveys and other data systems. Sexual behavior questions version 5.00. 2001 [5/27/2003.].
28.
go back to reference Metzger DS, Koblin B, Turner C, Navaline H, Valenti F, Holte S, et al. Randomized controlled trial of audio computer-assisted self-interviewing: utility and acceptability in longitudinal studies. HIVNET vaccine preparedness study protocol team. Am J Epidemiol. 2000;152(2):99–106.PubMedCrossRef Metzger DS, Koblin B, Turner C, Navaline H, Valenti F, Holte S, et al. Randomized controlled trial of audio computer-assisted self-interviewing: utility and acceptability in longitudinal studies. HIVNET vaccine preparedness study protocol team. Am J Epidemiol. 2000;152(2):99–106.PubMedCrossRef
29.
go back to reference Williams M, Bowen A, Ross M, Freeman R, Elwood W. Perceived compliance with AZT dosing among a sample of African-American drug users. Int J STD AIDS. 2000;11(1):57–63.PubMedCrossRef Williams M, Bowen A, Ross M, Freeman R, Elwood W. Perceived compliance with AZT dosing among a sample of African-American drug users. Int J STD AIDS. 2000;11(1):57–63.PubMedCrossRef
30.
go back to reference Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1:385–401.CrossRef Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1:385–401.CrossRef
31.
go back to reference Paterson DL, Swindells S, Mohr J, Brester M, Vergis EN, Squier C, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000;133:21–30.PubMed Paterson DL, Swindells S, Mohr J, Brester M, Vergis EN, Squier C, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000;133:21–30.PubMed
32.
go back to reference Jones DL, McPherson-Baker S, Lydston D, Camille J, Brondolo E, Tobin JN, et al. Efficacy of a group medication adherence intervention among HIV positive women: the SMART/EST Women’s Project. AIDS Behav. 2007;11(1):79–86.PubMedCrossRef Jones DL, McPherson-Baker S, Lydston D, Camille J, Brondolo E, Tobin JN, et al. Efficacy of a group medication adherence intervention among HIV positive women: the SMART/EST Women’s Project. AIDS Behav. 2007;11(1):79–86.PubMedCrossRef
Metadata
Title
Group Motivational Interviewing to Promote Adherence to Antiretroviral Medications and Risk Reduction Behaviors in HIV Infected Women
Authors
Marcia McDonnell Holstad
Colleen DiIorio
Mary E. Kelley
Kenneth Resnicow
Sanjay Sharma
Publication date
01-07-2011
Publisher
Springer US
Published in
AIDS and Behavior / Issue 5/2011
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-010-9865-y

Other articles of this Issue 5/2011

AIDS and Behavior 5/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.